• Sleep-wake disorders

Zolpimist Generic Name & Formulations

General Description

Zolpidem tartrate 5mg per metered actuation (one spray) in 100microliter; oral solution spray; cherry-flavored.

Pharmacological Class

Imidazopyridine hypnotic.

How Supplied

Pump—4.8g (30 actuations); 8.22g (60 actuations)


Generic Availability


Zolpimist Indications


Short-term treatment of insomnia (w. difficulties in sleep initiation).

Zolpimist Dosage and Administration


Use lowest effective dose. Effects delayed if taken with or after a meal. Spray directly into mouth over the tongue. Take once per night immediately before bedtime (with at least 7–8hrs remaining before planned time of awakening). Women: initially 5mg (one actuation). Men: initially 5mg or 10mg (two actuations). Both: if 5mg ineffective, may increase to max 10mg. Elderly, debilitated, or hepatic impairment: 5mg.


<18yrs: not recommended.

Zolpimist Contraindications


Prior history of complex sleep behaviors with Zolpimist.

Zolpimist Boxed Warnings

Boxed Warning

Complex sleep behaviors.

Zolpimist Warnings/Precautions


Risk of complex sleep behaviors (eg, sleep-walking, sleep-driving, engaging in other activities while not fully awake); discontinue immediately if occur. Monitor for CNS depressant effects and next-day impairment. Evaluate for co-morbid diagnoses (eg, physical and/or psychiatric disorders) prior to treatment. Reevaluate if insomnia fails to remit after 7–10 days of use. Depression. Suicidal tendencies. Evaluate any new onset of behavioral changes. Compromised respiratory function. Sleep apnea. Myasthenia gravis. Conditions that affect metabolism or hemodynamic response. Drug or alcohol abuse. Hepatic or renal impairment; monitor. Avoid abrupt cessation. Write ℞ for smallest practical amount. Elderly (higher risk of falls). Debilitated. Pregnancy (Cat.C). Nursing mothers.

Zolpimist Pharmacokinetics

See Literature

Zolpimist Interactions


Concomitant other sedative-hypnotics including other zolpidem products: not recommended. Potentiates CNS depression with alcohol, other CNS depressants (eg, benzodiazepines, opioids, tricyclics); adjust dose. May be potentiated by CYP3A4 inhibitors (eg, ketoconazole; consider lower zolpidem dose), sertraline. May be antagonized by CYP3A4 inducers (eg, rifampin). Decreased alertness with imipramine, chlorpromazine.

Zolpimist Adverse Reactions

Adverse Reactions

Drowsiness, dizziness, diarrhea, drugged feelings (long-term); abnormal thinking and behavioral changes; rare: anaphylaxis, angioedema (do not rechallenge).

Zolpimist Clinical Trials

See Literature

Zolpimist Note

Not Applicable

Zolpimist Patient Counseling

See Literature